Prostate Cancer Canada announces new President and CEO

Rocco Rossi to be succeeded by long-time health executive Peter Coleridge



Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada. Peter will begin effective February 28, 2018.

“After an extensive executive search process, I  and my colleagues on the national Board of Directors unanimously decided that Peter was the right individual to lead Prostate Cancer Canada’s next chapter and continue its tradition of excellence on behalf of Canadian men and their families,” said PCC Board Chair, Christopher Wein.

Coleridge, MHSc, has over 20 years of experience at the provincial, national and international levels in health and social services including population health, leadership and transformational change, business development, fundraising, social marketing, strategic communication, branding, public policy, education, research, and partnership development.  Coleridge has also served in other senior leadership roles in British Columbia and Ontario. He graduated with a Bachelor of Science in psychology from Memorial University in Newfoundland, and received his Master’s Degree in Health Science (Health Promotion) from the University of Toronto.  He has also completed an Executive Health Leadership program, Rotman School of Management, University of Toronto, in partnership with the Change Foundation and the Kings Fund in England, and served on several not-for-profit Boards.

“I am honored to be joining the PCC team and advancing a cause that touches us all,” Coleridge said.  “I am excited to build on Rocco’s legacy and work with the PCC team to lead the organization into the future.”

Since joining PCC in 2013, Rossi led PCC’s evolution to an increasingly professional and responsible charitable foundation. In particular, Rossi helped conceive and grow a number of innovative fundraising initiatives such as Plaid for Dad and the Step Up Challenge to advance PCC’s mission to improve outcomes for men with prostate cancer and their families through research, advocacy, education, support and awareness. In early December, Rossi and the team at PCC celebrated being selected as one of the top three Canadian health charities of 2017 in the Financial Post’s annual Charities of the Year list which grades charities across the country based on efficiency and financial transparency.

“When you’ve been inspired by so many incredible people along the way, and had the distinct honour of being part of a genuinely smart and dedicated team that has made a measurable difference in the lives of so many, saying goodbye can be an extremely difficult thing to do,” explained Rossi. “Knowing that Peter will be taking the helm brings me great comfort during this time of transition. To the 1 in 7 Canadian men who will be diagnosed with prostate cancer and their families, PCC is in good hands.”  
 
-30-
 
About Prostate Cancer Canada
Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness. As one of the largest investors in prostate cancer research in Canada, Prostate Cancer Canada is committed to continuous discovery in the areas of prevention, diagnosis, treatment, and support.

For more information:
Adam Miller
Prostate Cancer Canada
416-441-2131 ext. 235
adam.miller@prostatecancer.ca
Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive